Elena Gilbert*
The term "lung cancer" refers to cancers that begin in the lungs, typically in the bronchi or bronchioles or small air sacs (alveoli). The location of the cancer's origin determines how it is commonly referred to (your healthcare professional may use the term "cancer that is metastatic to your lungs").
The majority of cancer-related fatalities are caused by lung cancer, one of the most prevalent cancer forms worldwide. As a result, it is being researched to find new ways to treat and control it. This entails advancements in the direct treatment of lung cancer as well as improved diagnosis, which helps to enhance treatment results. The prognosis for people who are diagnosed with lung cancer has historically been dismal. Nonetheless, significant developments in detection and therapy over the past ten years have led to the first rises in lung cancer survival rates. The significant developments in palliative care, systemic targeted medicines, curative treatments, and early lung cancer diagnosis are highlighted in this overview. We cover the key studies that support these novel approaches/ strategies and where they stand in clinical practise now [1-5].
KeywordsLung cancer; Curative treatment; Early diagnosis; Lung cancer management; Targeted therapies
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi